|
1
|
Lee AS and Hendershot LM: ER stress and
cancer. Cancer Biol Ther. 5:721–722. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hoseki J, Ushioda R and Nagata K:
Mechanism and components of endoplasmic reticulum-associated
degradation. J Biochem. 147:19–25. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alasiri G, Fan LY, Zona S, Goldsbrough IG,
Ke HL, Auner HW and Lam EW: ER stress and cancer: The FOXO forkhead
transcription factor link. Mol Cell Endocrinol. 462:67–81. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rashid HO, Yadav RK, Kim HR and Chae HJ:
ER stress: Autophagy induction, inhibition and selection.
Autophagy. 11:1956–1977. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshida H: ER stress and diseases. FEBS J.
274:630–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hosoi T and Ozawa K: Endoplasmic reticulum
stress in disease: Mechanisms and therapeutic opportunities. Clin
Sci (Lond). 118:19–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ozcan U, Ozcan L, Yilmaz E, Düvel K, Sahin
M, Manning BD and Hotamisligil GS: Loss of the tuberous sclerosis
complex tumor suppressors triggers the unfolded protein response to
regulate insulin signaling and apoptosis. Mol Cell. 29:541–551.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim KM, Yu TK, Chu HH, Park HS, Jang KY,
Moon WS, Kang MJ, Lee DG, Kim MH, Lee JH and Chung MJ: Expression
of ER stress and autophagy-related molecules in human non-small
cell lung cancer and premalignant lesions. Int J Cancer.
131:E362–E370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferrari DM and Söling HD: The protein
disulphide-isomerase family: Unravelling a string of folds. Biochem
J. 339:1–10. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu S, Sankar S and Neamati N: Protein
disulfide isomerase: A promising target for cancer therapy. Drug
Discov Today. 19:222–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shai R, Shi T, Kremen TJ, Horvath S, Liau
LM, Cloughesy TF, Mischel PS and Nelson SF: Gene expression
profiling identifies molecular subtypes of gliomas. Oncogene.
22:4918–4923. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thongwatchara P, Promwikorn W, Srisomsap
C, Chokchaichamnankit D, Boonyaphiphat P and Thongsuksai P:
Differential protein expression in primary breast cancer and
matched axillary node metastasis. Oncol Rep. 26:185–191.
2011.PubMed/NCBI
|
|
14
|
Xia W, Zhuang J, Wang G, Ni J, Wang J and
Ye Y: P4HB promotes HCC tumorigenesis through downregulation of
GRP78 and subsequent upregulation of epithelial-to-mesenchymal
transition. Oncotarget. 8:8512–8521. 2017.PubMed/NCBI
|
|
15
|
Sevier CS and Kaiser CA: Ero1 and redox
homeostasis in the endoplasmic reticulum. Biochim Biophys Acta.
1783:549–556. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Araki K and Nagata K: Functional in vitro
analysis of the ERO1 protein and protein-disulfide isomerase
pathway. J Biol Chem. 286:32705–32712. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou B, Wang G, Gao S, Chen Y, Jin C, Wang
Z, Yang Y, Ma Z, Zhang W and Feng X: Expression of ERO1L in gastric
cancer and its association with patient prognosis. Exp Ther Med.
14:2298–2302. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seol SY, Kim C, Lim JY, Yoon SO, Hong SW,
Kim JW, Choi SH and Cho JY: Overexpression of endoplasmic reticulum
oxidoreductin 1-α (ERO1L) is associated with poor prognosis of
gastric cancer. Cancer Res Treat. 48:1196–1209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kutomi G, Tamura Y, Tanaka T, Kajiwara T,
Kukita K, Ohmura T, Shima H, Takamaru T, Satomi F, Suzuki Y, et al:
Human endoplasmic reticulum oxidoreductin 1-α is a novel predictor
for poor prognosis of breast cancer. Cancer Sci. 104:1091–1096.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tanaka T, Kutomi G, Kajiwara T, Kukita K,
Kochin V, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Okamoto
Y, et al: Cancer-associated oxidoreductase ERO1-α promotes immune
escape through up-regulation of PD-L1 in human breast cancer.
Oncotarget. 8:24706–24718. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC cancer staging manual. 8th. Springer
International Publishing; New York, NY: 2017, View Article : Google Scholar
|
|
22
|
Travis WD, Brambilla E, Burke A, Marx A
and Nicholson AG: WHO classification of tumours of the lung,
pleura, thymus and heart. 4th. IARC press; Lyon: 2015
|
|
23
|
Schoenborn CA and Adams PE: Health
behaviors of adults: United States, 2005–2007. Vital Health Stat.
10:1–132. 2010.
|
|
24
|
Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z,
Ma Y, Masliah E, Nomura Y and Lipton SA: S-nitrosylated
protein-disulphide isomerase links protein misfolding to
neurodegeneration. Nature. 441:513–517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Severino A, Campioni M, Straino S, Salloum
FN, Schmidt N, Herbrand U, Frede S, Toietta G, Di Rocco G, Bussani
R, et al: Identification of protein disulfide isomerase as a
cardiomyocyte survival factor in ischemic cardiomyopathy. J Am Coll
Cardiol. 50:1029–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lovat PE, Corazzari M, Armstrong JL,
Martin S, Pagliarini V, Hill D, Brown AM, Piacentini M,
Birch-Machin MA and Redfern CP: Increasing melanoma cell death
using inhibitors of protein disulfide isomerases to abrogate
survival responses to endoplasmic reticulum stress. Cancer Res.
68:5363–5369. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sipes NJ, Miller DA, Bascom CC, Winkler
JK, Matrisian LM and Moses HL: Altered regulation of protein
disulfide isomerase in cells resistant to the growth-inhibitory
effects of transforming growth factor beta 1. Cell Growth Differ.
1:241–246. 1990.PubMed/NCBI
|
|
28
|
Khan MM, Simizu S, Suzuki T, Masuda A,
Kawatani M, Muroi M, Dohmae N and Osada H: Protein disulfide
isomerase-mediated disulfide bonds regulate the gelatinolytic
activity and secretion of matrix metalloproteinase-9. Exp Cell Res.
318:904–914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kenche H, Ye ZW, Vedagiri K, Richards DM,
Gao XH, Tew KD, Townsend DM and Blumental-Perry A: Adverse outcomes
associated with cigarette smoke radicals related to damage to
protein-disulfide isomerase. J Biol Chem. 291:4763–4778. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kenche H, Baty CJ, Vedagiri K, Shapiro SD
and Blumental-Perry A: Cigarette smoking affects oxidative protein
folding in endoplasmic reticulum by modifying protein disulfide
isomerase. FASEB J. 27:965–977. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jorgensen E, Stinson A, Shan L, Yang J,
Gietl D and Albino AP: Cigarette smoke induces endoplasmic
reticulum stress and the unfolded protein response in normal and
malignant human lung cells. BMC Cancer. 8:2292008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
May D, Itin A, Gal O, Kalinski H,
Feinstein E and Keshet E: Ero1-L alpha plays a key role in a
HIF-1-mediated pathway to improve disulfide bond formation and VEGF
secretion under hypoxia: Implication for cancer. Oncogene.
24:1011–1020. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsu CH, Hsu CW, Hsueh C, Wang CL, Wu YC,
Wu CC, Liu CC, Yu JS, Chang YS and Yu CJ: Identification and
characterization of potential biomarkers by quantitative tissue
proteomics of primary lung adenocarcinoma. Mol Cell Proteomics.
15:2396–2410. 2016. View Article : Google Scholar : PubMed/NCBI
|
